Article
Efficacy and safety of Vosoritide in achondroplasia: A systematic review and meta-analysis.
The Indian journal of medical research - 1 Jan 2026
Pahuja Monika, Prakash Chander, Umrao Ankita, Chatterjee Nabendu Sekhar
Abstract excerpt
Background and objectives Achondroplasia, a rare autosomal dominant disorder caused by FGFR3 mutation, is treated with vosoritide, a C-type natriuretic peptide analogue. This review aimed to assess vosoritide's efficacy and safety to guide clinical practice and healthcare policy decisions. Methods Advanced search was performed on three databases. The included articles underwent screening, data extraction, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
